In a filing, Jaguar Health Inc. revealed its Chief of Staff, CCO & GC Wolin Jonathan S. acquired Company’s shares for reported $10.0 on Dec 31. In the deal valued at $0.03 per share,317 shares were bought. As a result of this transaction, Wolin Jonathan S. now holds 6,983 shares worth roughly $ 15083.28.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Cantor Fitzgerald initiated its Jaguar Health Inc. [JAGX] rating to an Overweight in a research note published on Friday, July 07, 2021; the price target was $5. PT values the company’s stock at a premium of 56.8 to its Friday closing price. A number of analysts have revised their coverage, including Rodman & Renshaw’s analysts, who began to cover the stock in mid July with a ‘”a Buy”‘ rating.
Price Performance Review of JAGX
On Friday, Jaguar Health Inc. [NASDAQ:JAGX] saw its stock fall -10.37% to $2.16. On the same session, the stock had its day’s lowest price of $2.15, but rose to a high of $2.35. Over the last five days, the stock has lost -34.55%. Jaguar Health Inc. shares have fallen nearly -66.86% since the year began. Nevertheless, the stocks have fallen -93.93% over the past one year. While a 52-week high of $61.12 was reached on 01/11/23, a 52-week low of $2.37 was recorded on 02/24/23. SMA at 50 days reached $5.64, while 200 days put it at $14.82. A total of 0.98 million shares were traded, compared to the trading of 1.64 million shares in the previous session.
Levels Of Support And Resistance For JAGX Stock
The 24-hour chart illustrates a support level at 2.09, which if violated will result in even more drops to 2.02. On the upside, there is a resistance level at 2.29. A further resistance level may holdings at 2.42. The Relative Strength Index (RSI) on the 14-day chart is 16.66, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.05, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.63%. Stochastics %K at 0.89% indicates the stock is a buying.
How much short interest is there in Jaguar Health Inc.?
A steep rise in short interest was recorded in Jaguar Health Inc. stocks on Jan 12, 2023, growing by 62210.0 shares to a total of 0.18 million shares. Yahoo Finance data shows the prior-month short interest on Dec 14, 2022 was 0.11 million shares. There was a rise of 35.52%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 8.69% of the overall stock float, the days-to-cover ratio (short ratio) rose to 1.01.
Jaguar Health Inc. [JAGX] – Who Are The Largest Shareholders?
In filings from The Vanguard Group, Inc., it is revealed that the company now owns 20,364 shares, or roughly 1.01% of the outstanding JAGX shares. In other words, the investor’s shares have fallen by -481 from its previous 13-F filing of 20845.0.. Over the last quarter, BlackRock Fund Advisors sold -19 shares of Jaguar Health Inc., while Geode Capital Management LLC sold -12 shares. At present, Morgan Stanley & Co. LLC is holding 3,265 shares valued at $14790.0. The Bank of New York Mellon Corp owned 2,236 shares of the company at the time of its most recent 13F filing, worth $10129.0.
According to FactSet, Jaguar Health Inc.’s share price will average $150.00 in the next year, based on opinions of analysts polled by the firm. This is up nearly 6124.07 percent from its previous closing price of $2.41. Analysts expect Jaguar Health Inc. stock to reach the higher price of $150.00, while the lowest price estimate is $150.00. However, 1 analyst have rated JAGX stock as a Buy in their predictions for 2023.